report #13-008: lab budgets and sources of funding in 2014 - the market outlook for the united...

30
gene2drug.com Life Science Industry Market Research

Upload: bioinformatics-llc

Post on 24-May-2015

616 views

Category:

Business


0 download

DESCRIPTION

In this multi-sponsor report, BioInformatics LLC will conduct an in-depth exploration of projected lab budgets and sources of funding by region, and the implications of these findings for the life science tools market in the coming year. The objective of this study is to assess sources of funding, the competitive landscape and market opportunities for life science tools companies. From the perspective of end-users, the goals of this assignment will be to: -Understand current sources of funding from government/stimulus/private foundation grants, distribution time frame and how labs initiate applications for funding. -Compare and contrast FY2013 (actual), and FY2014 (projected) average lab budgets in total by broad product category, region and market segment; providing directional information for FY2014. -Estimate scientists' budget for purchases and anticipated purchases in instrumentation and consumables, examining trends across key product categories. -Assess how optimistic scientists are regarding funding and the future of life science research. Contents, pricing and deadline ----------------------------------- BioInformatics LLC will deliver an in-depth analysis of the study's significant findings and their implications for your 2014 marketing strategy. A hard copy and an electronic version (PDF) of the final report will be provided to each sponsor. The final report will consist of the following sections: SECTION 1 - Overview and Regional Comparisons SECTION 2 - Market Analysis and Funding Situation for the United States SECTION 3 - Market Analysis for Funding Situation in Europe SECTION 4 - Market Analysis for Asia SECTION 5 - Study Methodology and Demographics SECTION 6 - Verbatim Comments from Survey Respondents Due to the high level of interest in this topic expressed by multiple life science suppliers and to defray the costs inherent in such a complex study, we are offering the report as a multi-sponsor opportunity. The fee for this study is $15,000 for each sponsor, but the report you will receive would be a $50,000-$60,000 investment for a single company to commission it individually. Please note that the deadline for inclusion in the October 2013 study is Friday, October 18, 2013.* For more information on this report, contact: Mary Follin Marketing/Sales Manager BioInformatics LLC 703.778.3080 ext. 13 [email protected] www.gene2drug.com *We will require a minimum of 6 sponsors to move forward with this study, so if you could indicate your intention to participate as soon as you've made a decision, that will be helpful to us for planning purposes.

TRANSCRIPT

Page 1: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

gene2drug.com Life Science Industry Market Research

Page 2: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com

Why We’re Here

• Economic landscape

• Report scope

• Being a sponsor

2

Page 3: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com 3

Your Feedback (Type questions in the box on the side of your screen)

Page 4: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com

About BioInformatics LLC

4

§ A full-service market research firm since 1994:

•  Published and syndicated reports

•  Consulting and strategy development

•  Expert interviews

•  Focus groups

•  Surveys

•  RateMyProduct™

Page 5: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com

About BioInformatics LLC

§ Conducting market research exclusively on scientific markets:

• Lab products

• Analytical instrumentation

• Biotechnology research & bioprocessing

• Drug discovery & development

• Molecular diagnostics

5

manufacturing  &  material  science

chemical,  food  &  beverage

environmental  testing

clinical  diagnostics

pharmaceutical agriculture  biotech

laboratory  products

life  sciences

Page 6: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com

About BioInformatics LLC

6

Project team includes scientists, statisticians and business analysts.

Instant access to a 74,000+ member expert scientific panel.

An Overview of Your Epigenetic Research

© 2009 BioInformatics, LLC www.gene2drug.com 3-17

* Totals are based on number of times an item was selected.* Percentages are based on number of respondents.

68%

57%

55%

47%

23%

20%

14%

10%

10%

5%

0% 10% 20% 30% 40% 50% 60% 70% 80%

Gene regulation

Disease mechanisms

Biomarkers

Basic biology of epigenetics

Therapeutic targets

Stem cells

Genomic imprinting

Transgenerational epigenetic

inheritance

Tissue repair/regeneration

X chromosome inactivation

Respondents 200

Gene regulation 135

Disease mechanisms 115

Biomarkers 110

Basic biology of epigenetics 94

Therapeutic targets 46

Stem cells 41

Genomic imprinting 27

Transgenerational epigenetic

inheritance 21

X chromosome inactivation 10

Question 9*

(check all that apply)

Conduct market research for major suppliers in the industry.

Page 7: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com

Introduction

Robin Rothrock, Ph.D.

Director of Publications

7

Page 8: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com 8

Overview of the Economic Landscape

Page 9: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com 9

Page 10: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com

United States

§ Sequester

§ Uncertainty regarding healthcare reform

§ Changes in molecular diagnostic tests coding and reimbursement

§ Flat to declining pharmaceutical R&D budgets

10

Page 11: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com

Europe

§ Continued fiscal austerity

§ Changes in healthcare institutions and funding

§ Funding of research is complex and multilayered

§ Cross-border collaboration is increasing

§ Leading institutions are taking action to be competitive with the U.S. in recruiting postdocs from India and China

11

Page 12: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com

China

§ Government and commercial investment: >$260 billion over the next 5 years

•  500 universities

• More than 150,000 life science graduates per year

•  Four innovation clusters

•  7,500 life science companies

•  200 life science incubators

•  100 life science parks

12

§  “Sea turtles” return §  Growth in pharmaceutical

market

Page 13: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com

A New Normal for Life Science Research

§ Slow global recovery

§ Unfavorable research funding

§ ñ pricing pressure

§ Growth in Asian markets may be slowing

13

Page 14: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com 14

Report Scope

Page 15: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com

Objectives

§ Understand current sources of funding

§ Compare and contrast FY2013 (actual), and FY2014 (projected) average lab budgets

§ Estimate scientists’ budget for purchases and anticipated purchases in instrumentation and consumables

§ Take the pulse of the life science community regarding funding and the future of life science research

15

Page 16: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com

Framework

Secondary research

§ An extensive review of relevant research councils, funding agencies and private funding sources

§ United States and Europe

Primary research

§ Quantitative survey administered to life scientists in the United States, Europe and Asia

§ Have budget authority

§ Sample size ≅ 1,000

§ 75% academic/gov’t and 25% life science industry

16

Page 17: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com

Questionnaire

§ Funding & Budgets • Current sources of funding

•  Average lab budgets (2013 and 2014) 

•  Average lab budgets for instrumentation

•  Average lab budgets for consumables

•  Percent budget allocation for overhead and salaries

•  Laboratory headcount

§ Techniques • Current usage

•  Explore adoption of new products/techniques in the next 12 months

•  Purchase of instrumentation (actual in 2013 and expected in 2014)

•  Identify new and emerging technologies

17

Page 18: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com

Customer Sentiment

18

Will my project be funded next year?

Page 19: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com

Product Categories

§ Instrumentation for… •  Cell-based analysis (flow cytometers,

high content analyzers, all microscopes, high throughput screening and analysis systems, etc.)

•  Genome analysis (thermal cyclers, real-time PCR instrumentation, microarray instrumentation, NGS, capillary electrophoresis, etc.)

•  Protein analysis (chromatography, electrophoresis, mass spectrometry, label-free detection, calorimetry, NMR, CD, etc.)

§ Consumables •  Cell-based analysis kits and reagents

(cell culture media and reagents, antibodies, cell biology kits, etc.)

•  Genome analysis kits and reagents (enzymes, kits, ladders, nucleic acid purification and separation products, oligonucleotides [primers, RNAi], etc.)

•  Protein purification and separation kits and reagents (chromatography media, electrophoresis matrices, protein ladders, etc.)

•  General laboratory chemicals, plasticware, glassware and disposables

19

Page 20: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com

Cell-Based Techniques

§ Bacteria Culture § Cell-Based Assays § Confocal Microscopy

§ Eukaryotic Cell/Tissue Culture § Flow Cytometry

§ Fluorescence Microscopy § Gene Expression Analysis § High Content Screening

§ High-Throughput Screening (HTS)

§  Immunohistochemistry

§ Light Microscopy § Stem Cell Culture/Analysis

20

Page 21: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com

Genomics Techniques

§ Classical End-Point PCR § Cloning/Molecular biology

Techniques

§ DNA/RNA Microarrays § Genotyping

§ Next Generation Sequencing § Real-Time PCR § RNAi (including siRNA, miRNA)

§ Sanger DNA Sequencing § Single Nucleotide Polymorphism

21

Page 22: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com

Protein Techniques

§  2-D Gel Electrophoresis

§ Calorimetry (including ITC, DSC)

§  Enzyme-linked Immunosorbent Assay (ELISA)

§  Label-Free Detection/Analysis (Including Biosensors, SPR, etc.)

§  Light Scattering (MALS, DLS)

§ Mass Spectrometry

§ Multiplex Bead Assays

§ Protein Purification & Separation

§ Protein Structural Analysis (NMR, CD, etc.)

§ Western Blotting

22

Page 23: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com

Deliverable

23

UK, France, Germany,

Spain, Italy, Switzerland & Scandinavia

China, India, South Korea, Singapore &

Japan

Page 24: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com 24

Why this report?

Page 25: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com

Share Gain/Share Protect Strategies

§ Where is the growth?

§ Funding trends?

§ Are researchers pitching their grants to follow the money?

25

Page 26: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com

How You Can Use It

§ Check assumptions

§ Make decisions

§ Forecast revenues

§ Identify potential growth

26

Page 27: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com

Benefits of Being a Sponsor

27

Cost Control

Start-up Time

Expertise

Objectivity

Efficiency

Page 28: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com

Fees

28

$80,000-$100,00

Cost of sponsorship is $15,000

Page 29: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com 29

Questions?

Page 30: Report #13-008: Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

Life Science Industry Market Research gene2drug.com

Contact

Mary Follin

Marketing/Sales Manager

703.778.3080 x13

[email protected]

30

Lab Budgets and Sources of Funding in 2014 Multi-Sponsor Research December 2013

CALL TODAY to BECOME A SPONSOR!